Self-management of oral anticoagulation in elderly patients - Effects on treatment-related Quality of Life

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages

  Siebenhofer, Andrea ^a   Hemkens, Lars G ^b   Rakovac, Ivo ^c   Spat, Stephan ^c   Didjurgeit, Ulrike ^d  

^a GOETHE UNIVERSITY   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOANNEUM RESEARCH Forschungsgesellschaft MbH   (Austria)

^d Institute for Evidence based Medicine GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; PHENPROCOUMON;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG SAFETY; EMPOWERMENT; EXERCISE; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; INTERMETHOD COMPARISON; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCORING SYSTEM; SELF CARE; SELF CONCEPT; SOCIAL NETWORK; STRUCTURED QUESTIONNAIRE; THROMBOEMBOLISM; TRAVEL; VENOUS THROMBOEMBOLISM;

ACTIVITIES OF DAILY LIVING; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CALIFORNIA; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PREVALENCE; QUALITY OF LIFE; SELF ADMINISTRATION; STRESS, PSYCHOLOGICAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84865229803     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.06.012     Document Type: Article

References (29)

1. M.I. Aguilar, and R. Hart Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks Cochrane Database Syst Rev 3 2005 CD001927
2. J. Ansell, J. Hirsh, L. Poller, H. Bussey, A. Jacobson, and E. Hylek The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl. 2004 204S 233S
3. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 13 1994 1449 1457
4. T.J. Bungard, W.A. Ghali, K.K. Teo, F.A. McAlister, and R.T. Tsuyuki Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 1 2000 41 46
5. N.K. Choudhry, G.M. Anderson, A. Laupacis, D. Ross-Degnan, S.L. Normand, and S.B. Soumerai Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis BMJ 332 7534 2006 141 145
6. N. Cohen, D. Almoznino-Sarafian, I. Alon, O. Gorelik, M. Koopfer, and S. Chachashvily Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission Stroke 31 6 2000 1217 1222
7. B.F. Gage, M. Boechler, A.L. Doggette, G. Fortune, G.C. Flaker, and M.W. Rich Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation Stroke 31 4 2000 822 827
8. E.M. Hylek, J. D'Antonio, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Translating the results of randomized trials into clinical practice: The challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation Stroke 37 4 2006 1075 1080
9. G. Palareti, N. Leali, S. Coccheri, M. Poggi, C. Manotti, and A. D'Angelo Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy Lancet 348 9025 1996 423 428
10. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 21 2007 2689 2696
11. H.E. Bloomfield, A. Krause, N. Greer, B.C. Taylor, R. MacDonald, and I. Rutks Meta-analysis: Effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes Ann Intern Med 154 7 2011 472 482
12. T.D. Christensen, S.P. Johnsen, V.E. Hjortdal, and J.M. Hasenkam Self-management of oral anticoagulant therapy: A systematic review and meta-analysis Int J Cardiol 118 1 2007 54 61
13. C. Heneghan, P. Alonso-Coello, J.M. Garcia-Alamino, R. Perera, E. Meats, and P. Glasziou Self-monitoring of oral anticoagulation: A systematic review and meta-analysis Lancet 367 9508 2006 404 411
14. C. Heneghan, A. Ward, R. Perera, C. Bankhead, A. Fuller, and R. Stevens Self-monitoring of oral anticoagulation: Systematic review and meta-analysis of individual patient data Lancet 379 9813 2012 322 334
15. P.S. Wells, A. Brown, J. Jaffey, L. McGahan, M.C. Poon, and K. Cimon Safety and effectiveness of point-of-care monitoring devices in patients on oral anticoagulant therapy: A meta-analysis Open Med 1 3 2007 e131 e146
16. B. Menendez-Jandula, J.C. Souto, A. Oliver, I. Montserrat, M. Quintana, and I. Gich Comparing self-management of oral anticoagulant therapy with clinic management: A randomized trial Ann Intern Med 142 1 2005 1 10
17. R.J. Beyth, L. Quinn, and C.S. Landefeld A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial Ann Intern Med 133 9 2000 687 695
18. A. Siebenhofer, I. Rakovac, C. Kleespies, B. Piso, and U. Didjurgeit Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial Thromb Haemost 100 6 2008 1089 1098
19. M.E. Cromheecke, M. Levi, L.P. Colly, B.J. de Mol, M.H. Prins, and B.A. Hutten Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison Lancet 356 9224 2000 97 102
20. D.A. Fitzmaurice, E.T. Murray, K.M. Gee, T.F. Allan, and F.D. Hobbs A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management J Clin Pathol 55 11 2002 845 849
21. D.A. Fitzmaurice, E.T. Murray, D. McCahon, R. Holder, J.P. Raftery, and S. Hussain Self management of oral anticoagulation: randomised trial BMJ 331 7524 2005 1057
22. A.P. Gadisseur, A.A. Kaptein, W.G. Breukink-Engbers, F.J. van der Meer, and F.R. Rosendaal Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life J Thromb Haemost 2 4 2004 584 591
23. S. Jowett, S. Bryan, E. Murray, D. McCahon, J. Raftery, and F.D. Hobbs Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis Br J Haematol 134 6 2006 632 639
24. P.T. Sawicki A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation JAMA 281 2 1999 145 150
25. M.A. Soliman Hamad, van Eekelen E, van Agt T, and A.H. van Straten Self-management program improves anticoagulation control and quality of life: a prospective randomized study Eur J Cardiothorac Surg 35 2 2009 265 269
26. D. McCahon, E.T. Murray, K. Murray, R.L. Holder, and D.A. Fitzmaurice Does self-management of oral anticoagulation therapy improve quality of life and anxiety? Fam Pract 28 2 2011 134 140
27. A. Siebenhofer, I. Rakovac, C. Kleespies, B. Piso, and U. Didjurgeit Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial Thromb Haemost 97 3 2007 408 416
28. R Development Core Team R: A Language and Environment for Statistical Computing www r-project org Available from: www.R-project.org 2006
29. T.I. Khan, F. Kamali, P. Kesteven, P. Avery, and H. Wynne The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation Br J Haematol 126 4 2004 557 564